Position in RPRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,407,174,637
+$317,043,410 QoQ
Shares Held
42,931,597
-1.5% QoQ
Ownership
7.47%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1
of 646 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 82%
Shared 3%
None 15%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. RPRX ranks #1 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in RPRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,407,174,637 | 42,931,597 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,090,131,227 | 43,571,633 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,135,790,017 | 55,274,069 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $1,558,104,290 | 44,163,954 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $1,679,145,826 | 46,604,103 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $1,277,258,663 | 41,029,832 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,008,480,957 | 39,532,770 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,162,101,227 | 41,078,163 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,163,798,964 | 44,133,446 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,342,897,163 | 44,217,885 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,302,091,327 | 46,354,266 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $1,306,319,165 | 48,132,615 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,457,993,921 | 47,429,861 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,706,036,997 | 47,350,458 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,946,203,178 | 49,246,032 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,016,479,945 | 50,186,161 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,166,874,904 | 51,543,171 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $2,085,988,056 | 53,541,788 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,240,792,994 | 56,230,690 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,071,013,937 | 57,305,311 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,082,047,737 | 50,794,041 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $2,098,917,713 | 48,118,242 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,191,093,953 | 23,798,081 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $394,053,617 | 9,366,618 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $301,261,778 | 6,205,186 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||